Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
Dihydromyricetin (DHM) is a flavonoid extracted from the leaves and stems of the edible plant Ampelopsis grossedentata that has been used for Chinese Traditional Medicine. It has attracted considerable attention from consumers due to its beneficial properties including anticancer, antioxidative, and...
Saved in:
Main Authors: | Liang Chen, Meng Shi, Chenghao Lv, Ying Song, Yuanjie Wu, Suifei Liu, Zhibing Zheng, Xiangyang Lu, Si Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2021/6692579 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-hyperglycemic effects of dihydromyricetin in streptozotocin-induced diabetic rats
by: Maojun Yao, et al.
Published: (2021-03-01) -
Antibacterial Effect of Dihydromyricetin on Specific Spoilage Organisms of Hybrid Grouper
by: Wenbo Huang, et al.
Published: (2021-01-01) -
Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway
by: Zhousheng Yang, et al.
Published: (2023-01-01) -
The Redox Process in Red Blood Cells: Balancing Oxidants and Antioxidants
by: Dala N. Daraghmeh, et al.
Published: (2024-12-01) -
Review on Molecular and Chemopreventive Potential of Nimbolide in Cancer
by: Perumal Elumalai, et al.
Published: (2014-12-01)